JRNGF(JRNGF)
JRNGF
No analyst ratings available
No analyst price targets available for JRNGF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $159M | $220M | $249M | $281M |
| Low | $159M | $220M | $249M | $281M |
| High | $159M | $220M | $249M | $281M |
| EBITDA Avg | $83M | $80M | $72M | $86M |
| Low | $83M | $80M | $72M | $86M |
| High | $83M | $80M | $72M | $86M |
| EBIT Avg | $35M | $31M | $21M | $32M |
| Low | $35M | $31M | $21M | $32M |
| High | $35M | $31M | $21M | $32M |
| Net Income Avg | $24M | $20M | $11M | $21M |
| Low | $24M | $20M | $11M | $21M |
| High | $24M | $20M | $11M | $21M |
| EPS Avg | $0.35 | $0.30 | $0.16 | $0.30 |
| Low | $0.35 | $0.30 | $0.16 | $0.30 |
| High | $0.35 | $0.30 | $0.16 | $0.30 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $57M | $59M | $61M | $63M | $65M | $67M |
| Low | $57M | $59M | $61M | $63M | $65M | $67M |
| High | $57M | $59M | $61M | $63M | $65M | $67M |
| EBITDA Avg | $24M | $25M | $23M | $20M | $21M | $21M |
| Low | $24M | $25M | $23M | $20M | $21M | $21M |
| High | $24M | $25M | $23M | $20M | $21M | $21M |
| EBIT Avg | $13M | $13M | $11M | $8M | $9M | $8M |
| Low | $13M | $13M | $11M | $8M | $9M | $8M |
| High | $13M | $13M | $11M | $8M | $9M | $8M |
| Net Income Avg | $10M | $10M | $8M | $5M | $7M | $6M |
| Low | $10M | $10M | $8M | $5M | $7M | $6M |
| High | $10M | $10M | $8M | $5M | $7M | $6M |
| EPS Avg | $0.14 | $0.14 | $0.12 | $0.07 | $0.09 | $0.08 |
| Low | $0.14 | $0.14 | $0.12 | $0.07 | $0.09 | $0.08 |
| High | $0.14 | $0.14 | $0.12 | $0.07 | $0.09 | $0.08 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |